Special Issue "Clinical Nutrition in the Management of Irritable Bowel Syndrome"

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Clinical Nutrition".

Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 2964

Special Issue Editor

Special Issue Information

Dear Colleagues,

Irritable Bowel Syndrome (IBS) represents the most common functional disorder of the gastrointestinal tract characterized by chronic or recurrent abdominal pain associated with altered bowel habits. The diferential diagnosis of IBS is very broad an include celiac disease, multiple food intolerances, food allergies colorectal cancer, neuroendocrine tumor, inflammatory bowel disaease, ischemic colitis, pancreatic insufficiency , small intestinal bacterial overgrowth,  psychiatric disorders and others.

The management of IBS is multifaceted including general measures, pharmacological therapy, diet (FODMAP-low diet), microbiota-modulating therapy (pre- pro- and synbiotics, fecal microbiota therapy) and complementary alternative therapies.

This issue is focused on the new developments in the diagnosis and treatment of IBS and the role of nutritional management in the treatment of this disease.

Prof. Dr. Peter C. Konturek
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • irritable bowel syndrome
  • microbiota-gut-brain axis
  • microbial
  • metabolites
  • COVID-19
  • histamine
  • mast cells
  • tryptase
  • histamine intolerance
  • motility
  • visceral pain
  • food allergy
  • food intolerance
  • FODMAP
  • therapy

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Article
Two Gold Kiwifruit Daily for Effective Treatment of Constipation in Adults—A Randomized Clinical Trial
Nutrients 2022, 14(19), 4146; https://doi.org/10.3390/nu14194146 - 06 Oct 2022
Viewed by 2746
Abstract
Chronic constipation is highly prevalent worldwide and may be managed with two green or three gold kiwifruit daily. It is unknown whether a smaller standard serve of gold kiwifruit (two daily) is as effective in constipation management. The study aimed to improve chronic [...] Read more.
Chronic constipation is highly prevalent worldwide and may be managed with two green or three gold kiwifruit daily. It is unknown whether a smaller standard serve of gold kiwifruit (two daily) is as effective in constipation management. The study aimed to improve chronic constipation with two gold kiwifruit and psyllium in lieu of a placebo daily over four weeks. Adult participants (18–65 years) with functional constipation (FC, n = 11), constipation-predominant irritable bowel syndrome (IBS-C, n = 13), and healthy controls (n = 32) were block-randomized to the treatment order: gold kiwifruit (2/day) or psyllium (fiber-matched, 7.5 g/day) for four weeks, followed by four weeks washout before crossover. Outcomes included alterations of Gastrointestinal Symptom Rating Scale (GSRS) domains and weekly complete spontaneous bowel movements (CSBM) as part of a larger study. Both interventions reduced GSRS constipation domain scores in all subjects compared to baseline values (p = 0.004). All participants reported significantly more weekly CSBM (p = 0.014). Two gold kiwifruit decreased straining (p = 0.021). Two gold kiwifruit daily are as effective as fiber-matched psyllium in treating constipation in adults and should be considered as a treatment option. Full article
(This article belongs to the Special Issue Clinical Nutrition in the Management of Irritable Bowel Syndrome)
Show Figures

Figure 1

Back to TopTop